ACIPC is a member of the National COVID-19 Clinical Evidence Taskforce. The Taskforce is conducting a brief survey to identify the uses, impacts, strengths and opportunities for improvement in the ongoing work of the Taskforce and guidelines. If you are an Australian healthcare practitioner, please help assist us by taking part in a brief survey. The survey closes on Monday 7 February.